$87.04
-0.94[-1.07%]
At close: May 28
$87.05
0.0100[0.01%]
After Hours: 4:15PM EDT
Edwards Lifesciences: Insider buying and selling updated today.
May 21, 2024 | Scott Ullem | CVP, CHIEF FINANCIAL OFFICER | 0 | $67.87 | -$254.12K | SELL-OPTIONS | 0.00% | 296.879K | May 21 | View |
May 13, 2024 | DONALD BOBO JR | CVP,STRATEGY/CORP DEVELOPMENT | -814 | $66.47 | -$283.24K | SELL | -0.45% | 182.0877184K | May 10 - May 11 | View |
May 09, 2024 | Daniel Lippis | CVP, JAPAC | 6.974K | $61.07 | -$91.73K | SELL-OPTIONS | 41.23% | 23.889744299999997K | May 07 | View |
May 07, 2024 | Bernard Zovighian | CEO | 2.6002600999999994K | $85.48 | -$312.03K | BUY | 389.61% | 3.2676552K | May 03 - May 06 | View |
May 02, 2024 | MICHAEL MUSSALLEM | DIRECTOR | 0 | $60.76 | -$1.41M | SELL-OPTIONS | 0.00% | 4.04286282M | May 02 | View |
May 01, 2024 | JeanLuc Lemercier | CVP, EMEACLA AND JAPAC | 0 | $60.48 | -$683.49K | SELL-OPTIONS | 0.00% | 173.8488055K | May 01 | View |
Apr 30, 2024 | Scott Ullem | CVP, CHIEF FINANCIAL OFFICER | 0 | $61.28 | -$355.62K | SELL-OPTIONS | 0.00% | 285.392K | Apr 30 | View |
Apr 09, 2024 | Daniel Lippis | CVP, JAPAC | 0 | $64.55 | -$47.64K | SELL-OPTIONS | 0.00% | 17.4877443K | Apr 09 | View |
Apr 08, 2024 | JeanLuc Lemercier | CVP, EMEACLA | 0 | $64.54 | -$800.27K | SELL-OPTIONS | 0.00% | 173.8488055K | Apr 08 | View |
Apr 08, 2024 | DONALD BOBO JR | CVP,STRATEGY/CORP DEVELOPMENT | 0 | $64.54 | -$694.77K | SELL-OPTIONS | 0.00% | 174.91971840000002K | Apr 08 | View |
Apr 04, 2024 | MICHAEL MUSSALLEM | DIRECTOR | 0 | $64.58 | -$1.63M | SELL-OPTIONS | 0.00% | 4.04286282M | Apr 04 | View |
Apr 01, 2024 | Scott Ullem | CVP, CHIEF FINANCIAL OFFICER | 0 | $65.82 | -$421.80K | SELL-OPTIONS | 0.00% | 285.392K | Apr 01 | View |
Mar 13, 2024 | DONALD BOBO JR | CVP,STRATEGY/CORP DEVELOPMENT | 0 | $63.88 | -$786.82K | SELL-OPTIONS | 0.00% | 174.6546931K | Mar 13 | View |
Mar 11, 2024 | JeanLuc Lemercier | CVP, EMEACLA AND JAPAC | 0 | $64.21 | -$790.95K | SELL-OPTIONS | 0.00% | 173.5837785K | Mar 11 | View |
Mar 07, 2024 | Daniel Lippis | CVP, JAPAC | 0 | $63.87 | -$93.00K | SELL-OPTIONS | 0.00% | 17.213210500000002K | Mar 07 | View |
Mar 04, 2024 | MICHAEL MUSSALLEM | DIRECTOR | 0 | $61.71 | -$1.47M | SELL-OPTIONS | 0.00% | 4.04286282M | Mar 04 | View |
Feb 29, 2024 | Scott Ullem | CVP, CHIEF FINANCIAL OFFICER | 0 | $61.17 | -$354.30K | SELL-OPTIONS | 0.00% | 285.392K | Feb 29 | View |
Feb 26, 2024 | KIERAN GALLAHUE | DIRECTOR | 3.998K | $62.24 | -$7.80K | SELL-OPTIONS | 6.32% | 67.219K | Feb 23 | View |
Feb 21, 2024 | Daveen Chopra | CVP, TMTT | -1.2K | $73.00 | -$296.47K | SELL | -5.01% | 22.75K | Feb 21 | View |
Feb 15, 2024 | Catherine Szyman | CVP, CRITICAL CARE | 0 | $61.36 | -$2.31M | SELL-OPTIONS | 0.00% | 34.813571K | Feb 13 - Feb 15 | View |
Feb 13, 2024 | DONALD BOBO JR | CVP,STRATEGY/CORP DEVELOPMENT | 0 | $61.29 | -$539.91K | SELL-OPTIONS | 0.00% | 174.6546931K | Feb 13 | View |
Feb 12, 2024 | WA ROBERT SELLERS | SVP, CORPORATE CONTROLLER | 0 | $61.88 | -$613.55K | SELL-OPTIONS | 0.00% | 33.4961838K | Feb 12 | View |
Feb 08, 2024 | LESLIE HEISZ STONE | DIRECTOR | 0 | $61.66 | -$349.88K | SELL-OPTIONS | 0.00% | 26.98K | Feb 08 | View |
Feb 05, 2024 | MICHAEL MUSSALLEM | DIRECTOR | 0 | $62.12 | -$1.49M | SELL-OPTIONS | 0.00% | 4.04286282M | Feb 05 | View |
Feb 01, 2024 | Scott Ullem | CVP, CHIEF FINANCIAL OFFICER | 0 | $57.52 | -$301.37K | SELL-OPTIONS | 0.00% | 285.566K | Feb 01 | View |
Jan 12, 2024 | DONALD BOBO JR | CVP,STRATEGY/CORP DEVELOPMENT | 0 | $56.21 | -$389.20K | SELL-OPTIONS | 0.00% | 174.6546931K | Jan 12 | View |
Jan 05, 2024 | MICHAEL MUSSALLEM | DIRECTOR | 0 | $54.87 | -$1.06M | SELL-OPTIONS | 0.00% | 4.04286282M | Jan 05 | View |
Dec 29, 2023 | Scott Ullem | CVP, CHIEF FINANCIAL OFFICER | 0 | $56.65 | -$577.55K | SELL-OPTIONS | 0.00% | 285.566K | Dec 29 | View |
Dec 15, 2023 | Daveen Chopra | CVP, TMTT | 0 | $68.75 | -$132.93K | SELL-OPTIONS | 0.00% | 23.95K | Dec 15 | View |
Dec 13, 2023 | DONALD BOBO JR | CVP,STRATEGY/CORP DEVELOPMENT | 0 | $54.30 | -$280.88K | SELL-OPTIONS | 0.00% | 174.6546931K | Dec 13 | View |
Browse insider trades on all stocks.